EBSEmergent BioSolutions Inc.

NYSE emergentbiosolutions.com


$ 12.11 $ 1.36 (12.66 %)    

Monday, 19-Aug-2024 15:59:59 EDT
QQQ $ 481.15 $ 6.24 (1.31 %)
DIA $ 409.09 $ 2.37 (0.58 %)
SPY $ 559.11 $ 5.30 (0.96 %)
TLT $ 97.90 $ 0.45 (0.46 %)
GLD $ 231.62 $ -0.38 (-0.16 %)
$ 12.1
$ 12.10 x 100
$ 12.13 x 400
-- - --
$ 1.42 - $ 15.10
12,006,292
na
636.46M
$ 1.13
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-01-2024 03-31-2024 10-Q
3 03-08-2024 12-31-2023 10-K
4 12-11-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-10-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-01-2022 06-30-2022 10-Q
10 04-28-2022 03-31-2022 10-Q
11 02-25-2022 12-31-2021 10-K
12 11-05-2021 09-30-2021 10-Q
13 07-30-2021 06-30-2021 10-Q
14 04-30-2021 03-31-2021 10-Q
15 02-19-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-01-2020 03-31-2020 10-Q
19 02-25-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-02-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 02-22-2019 12-31-2018 10-K
24 11-02-2018 09-30-2018 10-Q
25 08-03-2018 06-30-2018 10-Q
26 05-04-2018 03-31-2018 10-Q
27 02-23-2018 12-31-2017 10-K
28 11-03-2017 09-30-2017 10-Q
29 08-04-2017 06-30-2017 10-Q
30 05-05-2017 03-31-2017 10-Q
31 02-28-2017 12-31-2016 10-K
32 11-09-2016 09-30-2016 10-Q
33 08-05-2016 06-30-2016 10-Q
34 05-06-2016 03-31-2016 10-Q
35 02-29-2016 12-31-2015 10-K
36 11-06-2015 09-30-2015 10-Q
37 08-06-2015 06-30-2015 10-Q
38 05-08-2015 03-31-2015 10-Q
39 03-06-2015 12-31-2014 10-K
40 11-10-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 benchmark-reiterates-buy-on-emergent-biosolutions-maintains-8-price-target

Benchmark analyst Robert Wasserman reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $8 price target.

 emergent-biosolutions-bavarian-nordic-geovax-and-siga-technologies-shares-are-making-big-moves-thursday-whats-going-on

Several healthcare stocks associated with mpox are seeing increased attention Thursday after the World Health Organization decl...

 who-declares-mpox-public-health-emergency-coordinated-international-response-essential-to-halt-outbreak

A public health emergency for mpox in Africa saw vaccine stocks jump Wednesday. A look at the stocks and what's next for fi...

Core News & Articles

- Reuters

 benchmark-reiterates-buy-on-emergent-biosolutions-maintains-8-price-target

Benchmark analyst Robert Wasserman reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $8 price target.

 vaccine-maker-emergent-biosolutions-expects-deeper-losses-in-2024-stock-sinks

Emergent BioSolutions reported Q2 2024 sales of $254.7 million, beating estimates but showing a 25% decline year-over-year. Des...

 emergent-biosolutions-q2-2024-adj-eps-232-misses-094-estimate-sales-254700m-beat-190000m-estimate

Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(2.32) per share which missed the analyst consensus estimate of ...

 emergent-biosolutions-expands-narcan-nasal-spray-distribution-capabilities-nationwide

Customer-focused approach and continued investments in NARCAN® Nasal Spray supply-readiness efforts help ensure opioid emergenc...

 8-best-performing-small-caps-in-july-find-out-which-stock-jumped-803

Macro environment favors large-caps, but July saw impressive gains for small-caps, with Serve Robotics leading at 803% and Q32 ...

 emergent-biosolutions-announces-shelf-life-extension-for-narcan-nasal-spray-in-canada-from-36-months-to-48-months

The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioi...

 how-to-earn-500-a-month-from-american-express-stock-ahead-of-q2-earnings

American Express offers an annual dividend yield of 1.12%, or $2.80 a year. How can investors pocket a regular $500 monthly?

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION